Delivery Order SPE2DR25D2007-SPE2DR26FM26B
- Not listed
- The Defense Logistics Agency awarded a $20,062.40 delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 ml pen injectors on November 25, 2025, with completion targeted for November 26, 2025. This firm fixed-price delivery order, issued without set-aside designation, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract action under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injectors valued at $39,954.71, with completion scheduled for December 2, 2025. This competitive award with firm fixed pricing represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency awarded a $11,425.65 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zepbound 10 mg/0.5 mL pen injectors on November 25, 2025, with an ultimate completion date of November 26, 2025. This non-set-aside award represents a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical distributor,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Zepbound 5 mg/0.5 ml pen injectors at a firm fixed price ceiling value of $5,141.53. This is a non-set-aside, competitively awarded contract with an ultimate completion date of November 18, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $15,814 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pen injectors on November 12, 2025, with an ultimate completion date of November 13, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $2,531.04 to AmerisourceBergen Drug Corp for Zepbound 15 mg/0.5 mL pen injectors on August 6, 2025, with an ultimate completion date of August 7, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $23,327 delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injectors with an ultimate completion date of June 20, 2025. This firm fixed-price delivery order utilizes no set-aside designation and represents a competitively awarded contract for pharmaceutical medical supplies. The award is associated with AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Zepbound 10 mg/0.5 mL pen injectors with a ceiling value of $1,845.70 and an ultimate completion date of December 2, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $1 billion and extending through December 2026. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injectors valued at $4,448.25. This is a firm fixed-price delivery order with an ultimate completion date of November 18, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The contract was competitively awarded...
- The Defense Logistics Agency awarded a $1,023.15 delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injectors. This is a firm fixed price delivery order with an ultimate completion date of November 6, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's established capability to meet federal...
- SPE2DR25D2007Indefinite Delivery Contract
- SPE2DR25D2007-SPE2DR26FM26BDelivery Order
The Defense Logistics Agency awarded a $27,191.28 delivery order to AmerisourceBergen Drug Corp for Zepbound 5 mg/0.5 mL pen injectors on December 12, 2025, with a completion date of December 15, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitively awarded transaction supporting federal medical procurement needs. The award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania—the same location designated as the place of performance—is a major pharmaceutical distributor and critical vendor for federal medical supply chains. The company maintains an extensive portfolio of federal contract awards with the DLA, supplying brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order for Zepbound, a diabetes medication, exemplifies the company's role in supplying specialty pharmaceutical products to military and veteran healthcare systems through the DLA's competitive procurement process.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $27.2k | 12/11/25 |